Literature DB >> 24696079

Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences.

Alexander Wong1, Kirily Keats, Kieron Rooney, Callum Hicks, David J Allsop, Jonathon C Arnold, Iain S McGregor.   

Abstract

RATIONALE: Δ(9)-Tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, accumulates in fat tissue where it can remain for prolonged periods. Under conditions of increased fat utilisation, blood cannabinoid concentrations can increase. However, it is unclear whether this has behavioural consequences.
OBJECTIVES: Here, we examined whether rats pre-treated with multiple or single doses of THC followed by a washout would show elevated plasma cannabinoids and altered behaviour following fasting or exercise manipulations designed to increase fat utilisation.
METHODS: Behavioural impairment was measured as an inhibition of spontaneous locomotor activity or a failure to successfully complete a treadmill exercise session. Fat utilisation was indexed by plasma free fatty acid (FFA) levels with plasma concentrations of THC and its terminal metabolite (-)-11-nor-9-carboxy-∆(9)-tetrahydrocannabinol (THC-COOH) also measured.
RESULTS: Rats given daily THC (10 mg/kg) for 5 days followed by a 4-day washout showed elevated plasma THC-COOH when fasted for 24 h relative to non-fasted controls. Fasted rats showed lower locomotor activity than controls suggesting a behavioural effect of fat-released THC. However, rats fasted for 20 h after a single 5-mg/kg THC injection did not show locomotor suppression, despite modestly elevated plasma THC-COOH. Rats pre-treated with THC (5 mg/kg) and exercised 20 h later also showed elevated plasma THC-COOH but did not differ from controls in their likelihood of completing 30 min of treadmill exercise.
CONCLUSIONS: These results confirm that fasting and exercise can increase plasma cannabinoid levels. Behavioural consequences are more clearly observed with pre-treatment regimes involving repeated rather than single THC dosing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24696079     DOI: 10.1007/s00213-014-3532-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  False-positive cannabis results in Italian workplace drug testing.

Authors:  Nadia Fucci; Nadia De Giovanni
Journal:  Drug Test Anal       Date:  2012-02       Impact factor: 3.345

2.  The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007.

Authors:  Amanda Roxburgh; Wayne D Hall; Louisa Degenhardt; Jennifer McLaren; Emma Black; Jan Copeland; Richard P Mattick
Journal:  Addiction       Date:  2010-03-12       Impact factor: 6.526

3.  delta-9-Tetrahydrocannabinol uptake by adipose tissue: preferential accumulation in gonadal fat organs.

Authors:  A B Rawitch; R Rohrer; R M Vardaris
Journal:  Gen Pharmacol       Date:  1979

4.  Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.

Authors:  M Widman; S Agurell; M Ehrnebo; G Jones
Journal:  J Pharm Pharmacol       Date:  1974-11       Impact factor: 3.765

5.  Determination of delta 1-tetrahydrocannabinol in human fat biopsies from marihuana users by gas chromatography-mass spectrometry.

Authors:  E Johansson; K Norén; J Sjövall; M M Halldin
Journal:  Biomed Chromatogr       Date:  1989-01       Impact factor: 1.902

Review 6.  Dose related risk of motor vehicle crashes after cannabis use.

Authors:  J G Ramaekers; G Berghaus; M van Laar; O H Drummer
Journal:  Drug Alcohol Depend       Date:  2004-02-07       Impact factor: 4.492

7.  Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure.

Authors:  N Gunasekaran; L E Long; B L Dawson; G H Hansen; D P Richardson; K M Li; J C Arnold; I S McGregor
Journal:  Br J Pharmacol       Date:  2009-08-14       Impact factor: 8.739

8.  Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.

Authors:  David M Schwope; Wendy M Bosker; Johannes G Ramaekers; David A Gorelick; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2012-05-15       Impact factor: 3.367

9.  Higher levels of ATGL are associated with exercise-induced enhancement of lipolysis in rat epididymal adipocytes.

Authors:  Junetsu Ogasawara; Takuya Sakurai; Takako Kizaki; Yoshinaga Ishibashi; Tetsuya Izawa; Yoshikazu Sumitani; Hitoshi Ishida; Zsolt Radak; Shukoh Haga; Hideki Ohno
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Psychomotor function in chronic daily Cannabis smokers during sustained abstinence.

Authors:  Wendy M Bosker; Erin L Karschner; Dayong Lee; Robert S Goodwin; Jussi Hirvonen; Robert B Innis; Eef L Theunissen; Kim P C Kuypers; Marilyn A Huestis; Johannes G Ramaekers
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240

View more
  1 in total

1.  Toward a comprehensive model of ∆(9)-tetrahydrocannabinol pharmacokinetics using a population pharmacokinetics approach.

Authors:  Brett C Ginsburg
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.